The call for applications to showcase your cancer-related technology at the 2014 NCI SBIR Investor Forum, to be held on November 13, 2014 in Santa Clara, CA is now closed.
This event provides an exclusive opportunity for 10–15 selected NCI SBIR & STTR awardees to present their companies and other innovative cancer therapeutics, diagnostics, devices and other related technologies to an elite group of more than 200 potential strategic partners and venture capital, angel or other investors. An additional 10–15 applicants will be selected to present their products in a poster presentation.
Previous investor forums have been of great value to presenting companies; several companies have successfully leveraged Investor Forum contacts to complete large-scale deals with investors or strategic partners.
All small business corporations who have received a Phase I NCI SBIR/STTR award in 2012 or later, or Phase II NCI SBIR/STTR award in 2010 or later, were eligible to apply to be a featured company presenter and participate in this event.
Application Review Process
All applications are reviewed for technical and commercialization content by an independent panel of experts, including investors and strategic partners from the life science industry. Applications are pre-screened by the NCI SBIR Development Center staff to ensure that only suitable applications are sent to the review committee. The external review committee, will then work in collaboration with NCI SBIR program staff (including the Program Director assigned to your grant or contract) to select the presenting companies.
- Market opportunity
- Potential impact on cancer patients
- Stage of technology development
- Technology’s competitive advantage
- Company’s management team
- Company’s strengths, including IP portfolio, key strategic partnerships, and proprietary technologies or skills
- Fundraising potential
Contacts for Questions about the NCI Investor SBIR Forum Applications